BECTON DICKINSON & CO

Surgical & Medical Instruments & Apparatus·FRANKLIN LAKES, NJ·FY end 09/30·CIK 10795

CEO Pay Ratio

374:1

Thomas E. Polen

CEO Total Comp

$17.1M

Thomas E. Polen

Median Employee

$45,831

Revenue

$21.8B

FY 2025

Net Income

$1.7B

FY 2025

Free Cash Flow

—

FY 2025

Net Margin

7.7%

Insider Net (180d)

0 buys / 0 sales

CEO Pay Accountability

CEO comp as % of net income

1.02%

For every $1,000 of profit, $10.21 flows to the CEO.

CEO comp as % of buybacks

1.71%

CEO comp equals 17.1‰ of cash returned to shareholders via buybacks.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$21.8B	$20.2B	$19.4B	$18.9B	$20.2B
Gross Profit	—	—	—	—	—	—
Operating Income	$2.6B	$2.4B	$2.1B	$2.3B	$2.8B
Net Income	$1.7B	$1.7B	$1.5B	$1.8B	$2.1B
Operating CF	—	—	—	—	$4.6B	—
Capex	$760.0M	$725.0M	$874.0M	$973.0M	$1.2B
Free Cash Flow	—	—	—	—	$3.4B	—
Buybacks	$1.0B	$500.0M	$0	$500.0M	$1.8B
Dividends	$1.2B	$1.1B	$1.1B	$1.1B	$1.0B

Gross Margin	—	—	—	—	—	—
Operating Margin	11.8%	11.9%	10.9%	12.1%	13.8%
Net Margin	7.7%	8.4%	7.7%	9.4%	10.3%
FCF Margin	—	—	—	—	16.9%	—
R&D / Revenue	5.8%	5.9%	6.4%	6.7%	6.6%
Effective Tax	10.8%	15.0%	7.9%	8.3%	6.7%
Debt / Equity	0.69	0.69	0.57	0.55	0.72
Buybacks / FCF	—	—	—	—	51.2%	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Thomas E. PolenChairman, Chief Executive Officer and President	$1.4M	$3.3M	—	$11.8M	$578.0K	$17.1M
Michael D. GarrisonExecutive Vice President and President, Medical Essentials and BioPharma Systems Segments	$768.8K	$544.1K	—	$2.2M	$161.0K	$3.6M
Richard E. ByrdExecutive Vice President and President, Interventional Segment	$756.3K	$473.1K	—	$2.0M	$149.3K	$3.4M
Christopher J. DelOreficeExecutive Vice President and Chief Financial Officer	$837.5K	$1.0M	—	$3.9M	$6.0M	—
Michael C. FeldExecutive Vice President, Chief Revenue Officer and President, Life Sciences Segment	$775.0K	$544.1K	—	$2.2M	$4.7M	—